COVID Pfizer/Moderna covid vaccine research papers

Click For Summary
The Pfizer vaccine study published in the New England Journal of Medicine highlights its efficacy, showing a 95% effectiveness rate with a lower confidence interval of 90%. The analysis indicates that younger subjects experienced more frequent side effects, and the importance of receiving both doses is emphasized, as effectiveness after the first dose ranges from 30% to 68%. Discussions suggest that the observed protection begins approximately two weeks after the first dose, raising questions about the necessity of the second dose. The FDA's analysis relies on comprehensive data beyond published studies, and the potential for future research on a one-dose regimen is noted. Overall, the conversation underscores the complexities of vaccine efficacy and the regulatory processes involved.
  • #31
Ygggdrasil said:
The Moderna Phase 3 trial results have been published in the NEJM:

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
https://www.nejm.org/doi/10.1056/NEJMoa2035389
Excellent! Thanks for posting this!
 
  • Like
Likes Laroxe

Similar threads

Replies
4
Views
1K
Replies
4
Views
2K
  • · Replies 3 ·
Replies
3
Views
2K
  • · Replies 2 ·
Replies
2
Views
2K
  • · Replies 1 ·
Replies
1
Views
3K
  • · Replies 42 ·
2
Replies
42
Views
9K
  • · Replies 10 ·
Replies
10
Views
3K
Replies
3
Views
2K
  • · Replies 22 ·
Replies
22
Views
3K
Replies
1
Views
1K